tga bpc-157 approval status australia The has added illegal peptides to its 2026 compliance priorities as concerns grow about their use for performance and anti-ageing. Experts warn these unapproved products may carry serious safety risks, especially This is a joint statement
This is a joint statement from the TGA and Australia's Chief Medical Officer on concerns regarding the public health risks associated with unapproved peptide products. Australia's health leaders are increasingly concerned about BPC 157 in Australia: Benefits, side effects, risks and legality RACGP TGA issues warning against unapproved peptides As illegal peptide use in Australia continues to skyrocket, the TGA has formally deemed it such a risk to consumer safety it has made it a compliance priority for 2026 warning
Pay in 4 interest-free payments of $6.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
